Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.59
+0.07 (1.27%)
At close: Apr 28, 2026, 4:00 PM EDT
5.60
+0.01 (0.18%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $121.95 million as of April 28, 2026. Its market cap has decreased by -19.93% in one year.
Market Cap
121.95M
Enterprise Value
12.37M
1-Year Change
-19.93%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $121.95M, a decrease of -64.36%. That is a compound annual growth rate of -57.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 120.42M | -57.86% |
| Dec 31, 2025 | 285.77M | -16.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Equillium | 129.61M |
| Innate Pharma | 129.43M |
| Kalaris Therapeutics | 129.20M |
| Edesa Biotech | 126.71M |
| InflaRx | 120.73M |
| Vivani Medical | 115.97M |
| Cardiff Oncology | 114.85M |
| Cognition Therapeutics | 114.37M |